Security readout for executives and security teams
Plain-English summary
CVE-2019-13285 is a reported Host Header Injection issue in CoSoSys Endpoint Protector 5.1.0.2. The public record gives very limited detail: no CVSS score, no CWE, no confirmed patch, and no named exploitation. Treat it as a product-specific exposure to verify, not as a confirmed emergency from the provided evidence.
Executive priority
Set priority after asset confirmation. If Endpoint Protector 5.1.0.2 is deployed and reachable by untrusted users, schedule remediation review promptly. If not present, record the CVE as not applicable.
Technical view
The CVE record states that Endpoint Protector 5.1.0.2 allows Host Header Injection. Host header weaknesses can affect generated links, redirects, or request handling depending on implementation, but the provided sources do not describe impact, vulnerable endpoints, prerequisites, or remediation. KEV status is false in the bundle.
Likely exposure
Likely exposure is limited to organizations running CoSoSys Endpoint Protector 5.1.0.2. The provided sources do not identify affected configurations, deployment types, or whether internet exposure is required.
Exploitation context
The supplied bundle does not cite active exploitation, public exploit use, KEV listing, or technical proof-of-concept details. Exploitability and business impact remain unclear from the available evidence.
Researcher notes
Evidence is sparse. The record contains only a concise description and product references, without affected CPEs, CVSS, CWE, patch details, exploit status, or endpoint-level technical data. Avoid assuming impact beyond Host Header Injection.
Mitigation direction
- Inventory Endpoint Protector deployments and identify any version 5.1.0.2 instances.
- Check CoSoSys or Endpoint Protector vendor guidance for supported versions and remediation.
- Limit access to exposed Endpoint Protector web interfaces where operationally feasible.
- Review proxy and application configuration for strict accepted hostnames.
- Prioritize remediation if the product is internet-accessible or handles sensitive workflows.
Validation and detection
- Confirm installed Endpoint Protector version from asset records or product administration data.
- Review exposure paths for Endpoint Protector web components and management interfaces.
- Check vendor release notes or support channels for fixes after version 5.1.0.2.
- Look for security testing evidence showing host validation behavior was assessed.
- Document whether compensating controls restrict untrusted access to the product.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2019-13285 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://www.endpointprotector.com/products/endpoint-protectorCVE reference · x_refsource_MISC
- https://www.esecforte.com/endpoint-protector-india-cososys-dlp/CVE reference · x_refsource_MISC
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.